Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 30054Y107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
LSP 7 Cooperative UA
13D/A
|
14.7% |
2/19/2026
Event 2/12/2026
|
||
| LSP 7 Cooperatieve U.A. | 14.7% | |||
| LSP 7 Management B.V. | 14.7% | |||
|
Pivotal bioVenture Partners Fund I, L.P.
13G
|
10.9% |
2/13/2026
Event 12/31/2025
|
||
| Nan Fung Group Holdings Limited | 10.9% | |||
| NF Investment Holdings Limited | 10.7% | |||
| Nan Fung Life Sciences Holdings Limited | 10.7% | |||
| NFLS Platform Holdings Limited | 4.6% | |||
| NFLS Delta III Limited | 4.6% | |||
| Pivotal Life Sciences Holdings Limited | 6.1% | |||
| Pivotal Partners Ltd | 6.1% | |||
| Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 5.2% | |||
| Pivotal bioVenture Partners Fund I G.P., L.P. | 5.2% | |||
| Pivotal bioVenture Partners Fund I, L.P. | 5.2% | |||
| Pivotal bioVenture Partners Fund II G.P. Ltd | 0.9% | |||
| Pivotal bioVenture Partners Fund II, L.P. | 0.9% | |||
| NFLS Delta Limited | 4.6% | |||
|
RA Capital Management, L.P.
13D/A
|
9.7% |
2/17/2026
Event 2/12/2026
|
||
| RA Capital Management, L.P. | 9.7% | |||
| Peter Kolchinsky | 9.7% | |||
| Rajeev Shah | 9.7% | |||
| RA Capital Healthcare Fund, L.P. | 7.5% | |||
| Price T Rowe Associates Inc /MD/ 13G | 5.4% |
8/14/2026
Event 6/30/2026
|
||
|
Point72 Asset Management, L.P.
13G
|
5.3% |
7/16/2026
Event 7/15/2026
|
||
| Point72 Asset Management, L.P. | 5.3% | |||
| Point72 Capital Advisors, Inc. | 5.3% | |||
| Steven A. Cohen | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Andera Partners
13G/A
|
3.9% |
8/14/2026
Event 6/30/2026
|
||
| Andera Partners | 3.9% | |||
| BioDiscovery 6 FPCI | 3.9% | |||
| Stephane Bergez | 3.9% | |||
| Francois Xavier Mauron | 3.9% | |||